Prognomiq Announces $46 Million Financing To Advance Development Of Its Multi-Omics Product Pipeline For Early Detection And Treatment Of Cancer
Amount Raised
$46 Million
Round Type
Funding Round
San MateoBiotechnologyHealth CareScience And EngineeringDescription
PrognomiQ – a healthcare company focused on harnessing the power of multi-omics data to transform the detection and early treatment selection and monitoring of cancer and other complex diseases – today announced it has raised $46 million in financing led by Bruker Corporation, with participation from new investors, including Catalio Capital Management, and from existing investors including aMoon, Fidelity Management and Research Company LLC, funds and accounts advised by T. Rowe Price Associates, Inc., Invus, Maverick Ventures, Emerson Collective and Wing VC. The closing of this round brings PrognomiQ's total funding to more than $101 million since the company was founded in September 2020.
Quick answer
PrognomiQ raised $46 Million in a Funding Round round, dated March 15, 2022. PrognomiQ is based in San Mateo, California, United States.
- How much did PrognomiQ raise?
- PrognomiQ raised $46 Million in a Funding Round round on March 15, 2022.
- What does PrognomiQ do?
- PrognomiQ aims to generate proteomic information with high accuracy, scale and speed.
- Where is PrognomiQ based and how big is it?
- PrognomiQ is based in San Mateo, California, United States. Fundz records about 49 employees.
- Who are the decision-makers at PrognomiQ?
- Fundz holds 1 contact at PrognomiQ. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as PrognomiQ that raised within 45 days of this round, from Fundz verified event records.
- IMPLICITY raised $23M (Funding Round) on April 27, 2022.
- Unlearn raised $50M (Series B) on April 19, 2022.
- Unlearn raised $50M on April 19, 2022.
- Surf Bio raised $16M (Seed) on April 12, 2022.
- Ensem Therapeutics raised $67M (Series A) on April 6, 2022.
- Trait Biosciences Inc. raised $210K (Series A) on April 6, 2022.
Who to call at PrognomiQ, and when
A new round usually means PrognomiQ is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day PrognomiQ raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PrognomiQ, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PrognomiQ. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PrognomiQ raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
PrognomiQ raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.